Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Publications indexed to the term Receptors, Immunologic

FacultyTitle
1DNA hypomethylation ameliorates erosive inflammatory arthritis by modulating interferon regulatory factor-8. (Swarnkar G, Semenkovich NP, Arra M, Mims DK, Naqvi SK, Peterson T, Mbalaviele G, Wu CL, Abu-Amer Y) Proc Natl Acad Sci U S A 2024 Feb 13;121(7):e2310264121       1 Citation
1PD1+TIGIT+2B4+KLRG1+ Cells Might Underlie T Cell Dysfunction in Patients Treated with BCMA-Directed Chimeric Antigen Receptor T Cell Therapy. (Mishra AK, Schmidt TM, Martell EB, Chen AS, Dogru RE, Hematti P, Callander NS) Transplant Cell Ther 2024 Feb;30(2):191-202       1 Citation
1Molecular basis for lipid recognition by the prostaglandin D2 receptor CRTH2. (Liu H, Deepak RNVK, Shiriaeva A, Gati C, Batyuk A, Hu H, Weierstall U, Liu W, Wang L, Cherezov V, Fan H, Zhang C) Proc Natl Acad Sci U S A 2021 Aug 10;118(32)       10 Citations
1RIG-I and TLR4 responses and adverse outcomes in pediatric influenza-related critical illness. (Novak T, Hall MW, McDonald DR, Newhams MM, Mistry AJ, Panoskaltsis-Mortari A, Mourani PM, Loftis LL, Weiss SL, Tarquinio KM, Markovitz B, Hartman ME, Schwarz A, Junger WG, Randolph AG, PALISI Pediatric Intensive Care Influenza (PICFLU) Network Investigators) J Allergy Clin Immunol 2020 Jun;145(6):1673-1680.e11       16 Citations
1CD4+ and CD8+ T Cell Activation in Children with Hepatitis C. (Sheiko MA, Golden-Mason L, Giugliano S, Hurtado CW, Mack CL, Narkewicz MR, Rosen HR) J Pediatr 2016 Mar;170:142-8.e1       9 Citations
3Cooperative integrin/ITAM signaling in platelets enhances thrombus formation in vitro and in vivo. (Zhi H, Rauova L, Hayes V, Gao C, Boylan B, Newman DK, McKenzie SE, Cooley BC, Poncz M, Newman PJ) Blood 2013 Mar 07;121(10):1858-67       78 Citations
1HCV glycoprotein E2 is a novel BDCA-2 ligand and acts as an inhibitor of IFN production by plasmacytoid dendritic cells. (Florentin J, Aouar B, Dental C, Thumann C, Firaguay G, Gondois-Rey F, Soumelis V, Baumert TF, Nunès JA, Olive D, Hirsch I, Stranska R) Blood 2012 Nov 29;120(23):4544-51       49 Citations
1Genome-wide association and population genetic analysis of C-reactive protein in African American and Hispanic American women. (Reiner AP, Beleza S, Franceschini N, Auer PL, Robinson JG, Kooperberg C, Peters U, Tang H) Am J Hum Genet 2012 Sep 07;91(3):502-12       88 Citations
2Cross talk between NADPH oxidase and autophagy in pulmonary artery endothelial cells with intrauterine persistent pulmonary hypertension. (Teng RJ, Du J, Welak S, Guan T, Eis A, Shi Y, Konduri GG) Am J Physiol Lung Cell Mol Physiol 2012 Apr 01;302(7):L651-63       73 Citations
1S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways. (Nasser MW, Qamri Z, Deol YS, Ravi J, Powell CA, Trikha P, Schwendener RA, Bai XF, Shilo K, Zou X, Leone G, Wolf R, Yuspa SH, Ganju RK) Cancer Res 2012 Feb 01;72(3):604-15       97 Citations
1NAD(P)H oxidase and eNOS play differential roles in cytomegalovirus infection-induced microvascular dysfunction. (Leskov IL, Whitsett J, Vasquez-Vivar J, Stokes KY) Free Radic Biol Med 2011 Dec 15;51(12):2300-8       13 Citations
1The functional -374T/A polymorphism of the receptor for advanced glycation end products may modulate Crohn's disease. (Däbritz J, Friedrichs F, Weinhage T, Hampe J, Kucharzik T, Lügering A, Broeckel U, Schreiber S, Spieker T, Stoll M, Foell D) Am J Physiol Gastrointest Liver Physiol 2011 May;300(5):G823-32       39 Citations
1Evaluation of B7-H3 expression as a biomarker of biochemical recurrence after salvage radiation therapy for recurrent prostate cancer. (Parker AS, Heckman MG, Sheinin Y, Wu KJ, Hilton TW, Diehl NN, Pisansky TM, Schild SE, Kwon ED, Buskirk SJ) Int J Radiat Oncol Biol Phys 2011 Apr 01;79(5):1343-9       31 Citations
1T-cell co-regulatory molecule expression in renal angiomyolipoma and pulmonary lymphangioleiomyomatosis. (Boorjian SA, Sheinin Y, Crispen PL, Lohse CM, Leibovich BC, Kwon ED) Urology 2009 Dec;74(6):1359-64       9 Citations
1Expression of immunosuppresive B7-H3 ligand by hormone-treated prostate cancer tumors and metastases. (Chavin G, Sheinin Y, Crispen PL, Boorjian SA, Roth TJ, Rangel L, Blute ML, Sebo TJ, Tindall DJ, Kwon ED, Karnes RJ) Clin Cancer Res 2009 Mar 15;15(6):2174-80       70 Citations
1Silencing of directional migration in roundabout4 knockdown endothelial cells. (Kaur S, Samant GV, Pramanik K, Loscombe PW, Pendrak ML, Roberts DD, Ramchandran R) BMC Cell Biol 2008 Nov 03;9:61       42 Citations
1Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma. (Crispen PL, Sheinin Y, Roth TJ, Lohse CM, Kuntz SM, Frigola X, Thompson RH, Boorjian SA, Dong H, Leibovich BC, Blute ML, Kwon ED) Clin Cancer Res 2008 Aug 15;14(16):5150-7       224 Citations
1T-cell coregulatory molecule expression in urothelial cell carcinoma: clinicopathologic correlations and association with survival. (Boorjian SA, Sheinin Y, Crispen PL, Farmer SA, Lohse CM, Kuntz SM, Leibovich BC, Kwon ED, Frank I) Clin Cancer Res 2008 Aug 01;14(15):4800-8       238 Citations
1Deletion of PI3K-p85alpha gene impairs lineage commitment, terminal maturation, cytokine generation and cytotoxicity of NK cells. (Awasthi A, Samarakoon A, Dai X, Wen R, Wang D, Malarkannan S) Genes Immun 2008 Sep;9(6):522-35       28 Citations
2Bcl10 plays a divergent role in NK cell-mediated cytotoxicity and cytokine generation. (Malarkannan S, Regunathan J, Chu H, Kutlesa S, Chen Y, Zeng H, Wen R, Wang D) J Immunol 2007 Sep 15;179(6):3752-62       37 Citations
1B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy. (Roth TJ, Sheinin Y, Lohse CM, Kuntz SM, Frigola X, Inman BA, Krambeck AE, McKenney ME, Karnes RJ, Blute ML, Cheville JC, Sebo TJ, Kwon ED) Cancer Res 2007 Aug 15;67(16):7893-900       215 Citations
1Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT. (Miller JS, Cooley S, Parham P, Farag SS, Verneris MR, McQueen KL, Guethlein LA, Trachtenberg EA, Haagenson M, Horowitz MM, Klein JP, Weisdorf DJ) Blood 2007 Jun 01;109(11):5058-61       251 Citations
1Sialoadhesin deficiency ameliorates myelin degeneration and axonopathic changes in the CNS of PLP overexpressing mice. (Ip CW, Kroner A, Crocker PR, Nave KA, Martini R) Neurobiol Dis 2007 Jan;25(1):105-11       49 Citations
2Differential and nonredundant roles of phospholipase Cgamma2 and phospholipase Cgamma1 in the terminal maturation of NK cells. (Regunathan J, Chen Y, Kutlesa S, Dai X, Bai L, Wen R, Wang D, Malarkannan S) J Immunol 2006 Oct 15;177(8):5365-76       42 Citations
1The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry. (Farag SS, Bacigalupo A, Eapen M, Hurley C, Dupont B, Caligiuri MA, Boudreau C, Nelson G, Oudshoorn M, van Rood J, Velardi A, Maiers M, Setterholm M, Confer D, Posch PE, Anasetti C, Kamani N, Miller JS, Weisdorf D, Davies SM, KIR Study Group, Center for International Blood and Marrow Transplantation Research) Biol Blood Marrow Transplant 2006 Aug;12(8):876-84       217 Citations
1The balancing act: inhibitory Ly49 regulate NKG2D-mediated NK cell functions. (Malarkannan S) Semin Immunol 2006 Jun;18(3):186-92       21 Citations
1Attenuated demyelination in the absence of the macrophage-restricted adhesion molecule sialoadhesin (Siglec-1) in mice heterozygously deficient in P0. (Kobsar I, Oetke C, Kroner A, Wessig C, Crocker P, Martini R) Mol Cell Neurosci 2006 Apr;31(4):685-91       37 Citations
2Novel mechanism of vasodilation in inflammatory bowel disease. (Hatoum OA, Gauthier KM, Binion DG, Miura H, Telford G, Otterson MF, Campbell WB, Gutterman DD) Arterioscler Thromb Vasc Biol 2005 Nov;25(11):2355-61       25 Citations
1Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma. (Kröger N, Shaw B, Iacobelli S, Zabelina T, Peggs K, Shimoni A, Nagler A, Binder T, Eiermann T, Madrigal A, Schwerdtfeger R, Kiehl M, Sayer HG, Beyer J, Bornhäuser M, Ayuk F, Zander AR, Marks DI, Clinical Trial Committee of the British Society of Blood and Marrow Transplantation and the German Cooperative Transplant Group) Br J Haematol 2005 Jun;129(5):631-43       102 Citations
1Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. (Hsu KC, Keever-Taylor CA, Wilton A, Pinto C, Heller G, Arkun K, O'Reilly RJ, Horowitz MM, Dupont B) Blood 2005 Jun 15;105(12):4878-84       420 Citations
1Integration of Toll-like receptor and phagocytic signaling for tailored immunity. (Underhill DM, Gantner B) Microbes Infect 2004 Dec;6(15):1368-73       121 Citations
1NKG2D receptor-mediated NK cell function is regulated by inhibitory Ly49 receptors. (Regunathan J, Chen Y, Wang D, Malarkannan S) Blood 2005 Jan 01;105(1):233-40       53 Citations
1Glycine 420 near the C-terminal transmembrane domain of SR-BI is critical for proper delivery and metabolism of high density lipoprotein cholesteryl ester. (Parathath S, Sahoo D, Darlington YF, Peng Y, Collins HL, Rothblat GH, Williams DL, Connelly MA) J Biol Chem 2004 Jun 11;279(24):24976-85       25 Citations
1Monocyte surface-bound IL-15 can function as an activating receptor and participate in reverse signaling. (Neely GG, Epelman S, Ma LL, Colarusso P, Howlett CJ, Amankwah EK, McIntyre AC, Robbins SM, Mody CH) J Immunol 2004 Apr 01;172(7):4225-34       50 Citations
3Nitration of PECAM-1 ITIM tyrosines abrogates phosphorylation and SHP-2 binding. (Newman DK, Hoffman S, Kotamraju S, Zhao T, Wakim B, Kalyanaraman B, Newman PJ) Biochem Biophys Res Commun 2002 Sep 06;296(5):1171-9       36 Citations
1A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions. (Podrez EA, Poliakov E, Shen Z, Zhang R, Deng Y, Sun M, Finton PJ, Shan L, Febbraio M, Hajjar DP, Silverstein RL, Hoff HF, Salomon RG, Hazen SL) J Biol Chem 2002 Oct 11;277(41):38517-23       341 Citations
1CD36 and atherosclerosis. (Silverstein RL, Febbraio M) Curr Opin Lipidol 2000 Oct;11(5):483-91       109 Citations
1CD36 in atherosclerosis. The role of a class B macrophage scavenger receptor. (Nicholson AC, Febbraio M, Han J, Silverstein RL, Hajjar DP) Ann N Y Acad Sci 2000 May;902:128-31; discussion 131-3       66 Citations
1Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. (Podrez EA, Febbraio M, Sheibani N, Schmitt D, Silverstein RL, Hajjar DP, Cohen PA, Frazier WA, Hoff HF, Hazen SL) J Clin Invest 2000 Apr;105(8):1095-108       378 Citations
1Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. (Febbraio M, Podrez EA, Smith JD, Hajjar DP, Hazen SL, Hoff HF, Sharma K, Silverstein RL) J Clin Invest 2000 Apr;105(8):1049-56       859 Citations
1Subtle differences between human and rabbit neutrophil receptors shown by the secretagogue activity of constrained formyl peptides. (Dentino AR, Raj PA, De Nardin E) Arch Biochem Biophys 1997 Jan 15;337(2):267-74       9 Citations
2Peroxynitrite modification of low-density lipoprotein leads to recognition by the macrophage scavenger receptor. (Graham A, Hogg N, Kalyanaraman B, O'Leary V, Darley-Usmar V, Moncada S) FEBS Lett 1993 Sep 13;330(2):181-5       258 Citations
1Two distinct porcine natural killer lytic trigger molecules as PNK-E/G7 molecular complex. (Wierda WG, Johnson BD, Dato ME, Kim YB) Cell Immunol 1993 Feb;146(2):270-83       13 Citations
1Inhibition of acute myelogenous leukemia blast proliferation by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors. (Estrov Z, Kurzrock R, Estey E, Wetzler M, Ferrajoli A, Harris D, Blake M, Gutterman JU, Talpaz M) Blood 1992 Apr 15;79(8):1938-45       82 Citations
1Suppression of chronic myelogenous leukemia colony growth by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors: a novel application for inhibitors of IL-1 activity. (Estrov Z, Kurzrock R, Wetzler M, Kantarjian H, Blake M, Harris D, Gutterman JU, Talpaz M) Blood 1991 Sep 15;78(6):1476-84       92 Citations
1The classical and alternate pathways of T cell activation are impaired in leprosy. (Muthukkaruppan V, Chakkalath HR, Malarkannan S) Immunol Lett 1988 Sep;19(1):55-8       4 Citations
1Comparative responses of human polymorphonuclear leukocytes obtained by counterflow centrifugal elutriation and Ficoll-Hypaque density centrifugation. II. Membrane potential changes, membrane receptor analysis, membrane fluidity, and analysis of the effects of the preparative techniques. (Berkow RL, Weisman SJ, Tzeng D, Haak RA, Kleinhans FW, Barefoot S, Baehner RL) J Lab Clin Med 1984 Nov;104(5):698-710       13 Citations
1Chlorpromazine inhibits neutrophil chemotaxis beyond the chemotactic receptor-ligand interaction. (Lohr KM, Feix JB, Kurth C) J Infect Dis 1984 Nov;150(5):643-52       16 Citations